We are live on ! Find out more
BSX.PRA

Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A

Delisted

BSX.PRA was delisted on the 31st of May, 2023.

43 hedge funds and large institutions have $1.08B invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $1B → $1.08B (+$74.7M)

7% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 14

12% less funds holding

Funds holding: 4943 (-6)

43% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 14

Holders
43
Holders Change
-6
Holders Change %
-12.24%
% of All Funds
0.87%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
8
Increased
13
Reduced
14
Closed
14
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AGC
51
Angelo Gordon & Co
New York
-$3.48M -33,200 Closed
BCM
52
BlueCrest Capital Management
Jersey
-$2.59M -24,726 Closed
CL
53
CSS LLC
Illinois
-$2.52M -24,047 Closed
Bank of New York Mellon
54
Bank of New York Mellon
New York
-$1.57M -15,000 Closed
CCM
55
CAAS Capital Management
New York
-$1.05M -10,000 Closed
TSS
56
Two Sigma Securities
New York
-$974K -9,302 Closed
VSI
57
Verde Servicos Internacionais
Brazil
-$523K -5,000 Closed
CIC
58
Chase Investment Counsel
Virginia
-$369K -3,520 Closed

BSX.PRA Hedge Fund Activity: Q3 2020 in Review

43 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q3 2020, worth a combined $1.08B — up 7.5% from $1B a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of BSX.PRA and 8 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 13 added.

The largest buyer was Capital World Investors, adding an estimated $46.1M. The largest seller was Camden Asset Management, exiting entirely with an estimated $37.3M sold.

  • 43 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q3 2020, down from 49 in Q2 2020.
  • Funds reported $1.08B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q3 2020, up 7.5% quarter-over-quarter.
  • 8 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q3 2020 and 14 closed out, a net change of -6 holders.
  • The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q3 2020 was Capital World Investors, an estimated $46.1M added.
  • The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q3 2020 was Camden Asset Management, an estimated $37.3M sold.

Based on aggregated 13F filings for Q3 2020.